Preadministration of Lorazepam Negates the Long-Term Antidepressant-Like Effects of Psilocybin in Male Wistar Kyoto Rats
Psychedelic Medicine · 01.09.2026 · 4 (3) · 186-198
DOI: 10.1177/28314425251393186 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psychedelic Medicine, online erschienen am 16.12.2025. Verfasst von Sophie Woodruff und 2 weiteren Autor:innen. Die Arbeit nennt 71 Literaturangaben. Gefördert von: 2A Biosciences.
Abstract (Originalsprache)
Introduction
Psilocybin, a classical psychedelic, has shown to produce persistent antidepressant effects, including in patients with treatment-resistant depression. In clinical practice, it is common to coprescribe benzodiazepines (BZDs) alongside antidepressants. However, our preliminary study indicated that preadministration of lorazepam diminished the antidepressant-like efficacy and longevity of psilocin. These results raise concern about the potential reduction of therapeutic benefits in psilocybin-assisted therapy for patients concurrently prescribed BZDs. The current study aimed to confirm these results while exploring psilocybin’s long-term effects on neuroplasticity-related gene expression in the medial prefrontal cortex.
Methods
Male Wistar Kyoto rats were given saline (S/S), lorazepam (L/S), psilocybin (S/P), or lorazepam followed by psilocybin (L/P). Treatments were delivered as two intraperitoneal injections separated by 30 min. Rats were tested in the forced swim test at 3, 5, 7, 9, and 11 weeks post-treatment. Tissue punches from the anterior cingulate cortex, prelimbic cortex (PL), and infralimbic cortex were collected for quantitative PCR analysis of 17 targets normalized to Ywhaz .
Results
S/P rats exhibited sustained antidepressant-like effects for up to 9 weeks compared with control (S/S). L/P rats did not exhibit antidepressant-like effects at any time point, similarly to S/S. Lorazepam was associated with a decrease in Gria3 expression, and psilocybin was associated with an increase in Gria4 expression at 12 weeks post-treatment in the PL.
Conclusions
Psilocybin produced long-lasting antidepressant-like effects, and administration of a BZD prior to psilocybin prevented these effects. Two genes were altered in response to treatment; however, their implications in antidepressant-like effects remain elusive.
Förderung
- 2A Biosciences
Zitieren
APA
Woodruff, S., Hibicke, M., & Nichols, C. D. (2026). Preadministration of Lorazepam Negates the Long-Term Antidepressant-Like Effects of Psilocybin in Male Wistar Kyoto Rats. Psychedelic Medicine, 4(3), 186-198. https://doi.org/10.1177/28314425251393186
Vancouver
Woodruff S, Hibicke M, Nichols CD. Preadministration of Lorazepam Negates the Long-Term Antidepressant-Like Effects of Psilocybin in Male Wistar Kyoto Rats. Psychedelic Medicine. 2026;4(3):186-198. doi:10.1177/28314425251393186
BibTeX
@article{Woodruff2026,
author = {Woodruff, Sophie and Hibicke, Meghan and Nichols, Charles D.},
title = {Preadministration of Lorazepam Negates the Long-Term Antidepressant-Like Effects of Psilocybin in Male Wistar Kyoto Rats},
journal = {Psychedelic Medicine},
year = {2026},
volume = {4},
number = {3},
pages = {186--198},
doi = {10.1177/28314425251393186}
}
EUVIMED